Fig. 6: Ad-shPRC1 treatment suppresses development of orthotopic HCC xenografts and protects hepatic function. | Cell Death & Disease

Fig. 6: Ad-shPRC1 treatment suppresses development of orthotopic HCC xenografts and protects hepatic function.

From: Reducing protein regulator of cytokinesis 1 as a prospective therapy for hepatocellular carcinoma

Fig. 6

a The livers with orthotopic HCC xenografts under different treatments; tumor nodules are indicated with yellow arrows. b Serum AST and ALB levels of the orthotopic HCC xenografted mice at 21 days after receiving different treatments. c A potential mechanism for dual-mitotic suppression strategy for treating HCC. (*P < 0.05)

Back to article page